Omada Health priced its IPO at $19 per share on Thursday, in the middle of the expected range. The virtual chronic care company said in a press release that 7.9 million shares are being sold in the offering, amounting to $150 million. Omada, founded in 2012, will trade on the Nasdaq under the ticker symbol…
Biopharmaceutical stocks’ underperformance versus the broader market for a third straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm’s June outlook for biopharma that the sector’s poor performance can be traced back to concerns over President Donald Trump’s tariffs and his ” most favored nation ” executive…
Omada Health shares rose 21% in their Nasdaq debut Friday after the virtual chronic care company priced its stock at $19 per share in its IPO. The stock opened at $23 and closed at that same level, reaching a high of $28.40 in the middle of the day. The company said in a press release…
The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their first season of the virus, bringing to market a rival to a similar treatment from Sanofi and AstraZeneca. The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead…
Health and Human Services Secretary Robert F. Kennedy Jr. on Monday said he is “retiring” all 17 members of a crucial government panel of vaccine advisors, a shocking step that could help to sow doubts about immunizations in the U.S. “A clean sweep is needed to re-establish public confidence in vaccine science,” Kennedy said in…
When the idea for the Oura Ring was first spawned in 2013, the company’s founders envisioned a device that would take a precise look at sleep and recovery, two important aspects of overall health that they felt few wearable tools had prioritized to that point. Now, over a decade later, Oura’s ambitions have evolved to…
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. leaves the stage after discussing the findings of the Centers for Disease Control and Prevention’s (CDC) latest Autism and Developmental Disabilities Monitoring (ADDM) Network survey, at the Department of Health and Human Services in Washington, D.C., U.S., April 16, 2025. Elizabeth Frantz | Reuters…
Weight loss syringes of the brands “Wegovy”, “Ozempic” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novo…
23andMe founder Anne Wojcicki speaks during a House Committee on Oversight and Government Reform hearing in Washington, D.C., on June 10, 2025. Andrew Harnik | Getty Images Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained control over the embattled genetic testing company after her new nonprofit, TTAM Research Institute, outbid Regeneron Pharmaceuticals,…
Cases of Kool-Aid Jammers are stacked at a Costco Wholesale store on April 27, 2025 in San Diego, California. Kevin Carter | Getty Images Kraft Heinz said Tuesday that it will remove FD&C artificial dyes from its products by the end of 2027, and will not launch any new products in the U.S. containing those…
